Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Observational Studies:Integrative TCM and Western Medicine for Breast Cancer
Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Summary
The aim of this study is to investigate the intervention of traditional Chinese medicine (TCM) in managing the side effects experienced by breast cancer patients undergoing conventional Western medical treatments, such as blood cell decline, nausea, vomiting, gastrointestinal discomfort, and overall quality of life. The study aims to establish a long-term clinical enrollment criteria and process for TCM adjuvant therapy in breast cancer. The research design will utilize a prospective cohort study and real-world cross-sectional observational research method to obtain clinical data and survival status of the patients.
Official title: Clinical Observational Studies: Breast Cancer Treatment by Traditional Chinese and Western Medicine
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2024-01-01
Completion Date
2026-12-31
Last Updated
2025-07-31
Healthy Volunteers
No
Conditions
Interventions
Chemotherapy drug
Participants in the standard care group receive conventional chemotherapy for breast cancer according to clinical guidelines. Treatment includes 8 cycles of chemotherapy administered every 3 weeks. No Traditional Chinese Medicine (TCM) is provided in this group.
Integrative Treatment (Chemotherapy + TCM)
Participants in the integrative care group receive conventional chemotherapy combined with Traditional Chinese Medicine (TCM) treatment. Herbal formulas are prescribed by licensed TCM physicians based on syndrome differentiation and are aimed at strengthening vital qi and harmonizing stomach function. Treatment is conducted under Taiwan's National Health Insurance coverage.
Locations (1)
Buddhist Taipei Tzu Chi General Hospital
New Taipei City, Taiwan